BioSpace News Archive

Pulse Biosciences, Inc. announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 23,750 shares of Pulse Biosciences common stock to three recently hired non-executive employees under the Pulse Biosciences 2017 Inducement Equity Incentive Plan on October 15, 2019.

This collaboration brings together AskBio’s leading capsid development, clinical stage AAV vector delivery system, and manufacturing expertise with Editas Medicine’s leading genome editing technologies to potentially develop novel medicines for patients with high unmet need.

New Website Address is www.redhawkholdingscorp.com

BOSTON, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic disorders of obesity, today announced the pricing of its public offering of 8,108,108 shares of its common stock at a public offering price of $18.50 per share. All of the shares are being offered by Rhythm. In addition, Rhythm has granted the underwriters a 30-day option to purchase

AAID-credentialed dentists celebrate 68 years of advancements in the field

For the first time, the American Lung Association, the American Diabetes Association (ADA), and the American Heart Association (AHA) have come together to raise an important alert about the dangers of influenza (flu) for people with chronic health conditions, including diabetes, heart disease and lung diseases such as asthma and COPD

MHK (formerly MedHOK), part of the Hearst Health network, announced today the launch of the next version of its CareProminence SaaS platform, introducing new features and functionality to help managed care organizations meet changing regulatory requirements, streamline operations, enhance user productivity, and improve member care.

The AMN Healthcare Team Hope Mission to Guatemala, which provides life-changing and sustainable assistance to people in the country’s impoverished highlands, has been awarded the American Staffing Association’s top Care Award for exceptional corporate social responsibility.

Aro Biotherapeutics Company announces that co-founder and Chief Scientific Officer Karyn O’Neil, PhD, debuted ABX300, the company’s lead Centyrin™-pan-KRAS siRNA program, during a presentation today at the 2019 Oligonucleotide Therapeutic Society (OTS) meeting in Munich, Germany.

Horizon Eye Specialists & Lasik Center, the leading comprehensive eye care center in Arizona, announces it has started offering the latest generation in multifocal implants, the AcrySof IQ PanOptix lens by Alcon.